Cancer Patient Sees Total Remission With CU Anschutz-Created Cell Therapy
Clinical trial uses CAR-T cells made steps away at the Gates Biomanufacturing Facility Author David Kelly | Publish Date February 8, 2021
Feb 8, 2021
Tags:
2021
patient care
research
